# Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19

> **NCT04465695** · PHASE2 · UNKNOWN · sponsor: **The University of Hong Kong** · enrollment: 81 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Interferon beta-1b
- **DRUG:** Clofazimine

## Key facts

- **NCT ID:** NCT04465695
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-14
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-09-30
- **Target enrollment:** 81 (ESTIMATED)
- **Last updated:** 2020-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04465695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04465695, "Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04465695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*